Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR | Market Cap | 2.29B +10.8% |
| Revenue (ttm) | 1.18B -1.4% |
| Net Income | 132.41M +16.4% |
| EPS | 2.46 +16.4% |
| Shares Out | 49.54M |
| PE Ratio | 18.79 |
| Forward PE | 17.62 |
| Dividend | 0.88 (1.90%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 11,570 |
| Average Volume | 16,884 |
| Open | 47.15 |
| Previous Close | 46.20 |
| Day's Range | 46.10 - 47.15 |
| 52-Week Range | 31.70 - 47.80 |
| Beta | 0.86 |
| RSI | 57.63 |
| Earnings Date | May 13, 2026 |
About Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a... [Read more]
Full Company ProfileFinancial Performance
In 2025, Dermapharm Holding SE's revenue was 1.18 billion, a decrease of -1.43% compared to the previous year's 1.20 billion. Earnings were 132.41 million, an increase of 16.37%.
Financial StatementsNews
EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements Dermapharm Holding SE: Preliminary announcement of the public...
EQS-NVR: Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Total Voting Rights Announcement: Dermapharm Holding SE / Total Voting Rights Announcement Dermapharm Holding SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] wi...
EQS-PVR: Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG
EQS Voting Rights Announcement: Dermapharm Holding SE Dermapharm Holding SE: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG 07.04.2026 / 10:08 C...